Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 10:18 PM
Study NCT ID:
NCT00229658
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2005-09-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-28
First Submit QC Date:
None
Study First Post Date:
2005-09-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-05-05
Results First Submit QC Date:
None
Results First Post Date:
2009-06-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-05
Last Update Post Date:
2015-03-25
Last Update Post Date Type:
ESTIMATED